Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial
Open Access
- 31 July 2004
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 191 (1), 235-240
- https://doi.org/10.1016/j.ajog.2003.11.034
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Fetal fibronectin: The impact of a rapid test on the treatment of women with preterm labor symptomsAmerican Journal of Obstetrics and Gynecology, 2003
- The management of preterm labor*1Obstetrics & Gynecology, 2002
- Pregnancy outcome in women with preterm labor symptoms without cervical changeAmerican Journal of Obstetrics and Gynecology, 2001
- Economic burden of hospitalizations for preterm labor in the United StatesObstetrics & Gynecology, 2000
- The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savingsAmerican Journal of Obstetrics and Gynecology, 2000
- Impact of the fetal fibronectin assay on admissions for preterm laborAmerican Journal of Obstetrics and Gynecology, 1999
- Fetal Fibronectin as a Predictor of Preterm Birth: An OverviewAmerican Journal of Perinatology, 1998
- Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trialAmerican Journal of Obstetrics and Gynecology, 1997